Status:
UNKNOWN
Endoclip Papillaplasty Restores Sphincter of Oddi Function
Lead Sponsor:
Peking University Third Hospital
Conditions:
Sphincter of Oddi Function
Eligibility:
All Genders
18-85 years
Brief Summary
Gallstones in the common bile duct (CBD) may be asymptomatic but may lead to complications such as acute cholangitis or acute pancreatitis. EST is widely used for the treatment of bile duct gallstones...
Detailed Description
Gallstones in the common bile duct (CBD) may be asymptomatic but may lead to complications such as acute cholangitis or acute pancreatitis. EST is widely used for the treatment of bile duct gallstones...
Eligibility Criteria
Inclusion
- \- 1)18-85 years of age; 2) informed consent obtained before ERCP; 3) CBD diameter ≥12 mm; 4) CBD gallstones visualized at magnetic resonance cholangiopancreatography (MRCP) with at least one gallstone ≥10 mm (transverse diameter)
Exclusion
- gallstone transverse diameter \>35 mm, which is not appropriate to be extracted;
- history of previous sphincterotomy, previous EPBD;
- accompanied with choledochoduodenal fistula, coagulopathy, anticoagulant/antiplatelet therapy, or Billroth II or Roux-en-Y reconstruction;
- papilla located deep within a diverticulum;
- small papilla and short intramural segment, which was not suitable for large EST;
- medications known to affect the SO (calcium channel blockers, nitrates, opiates, and anticholinergics) taken within 48 h of the procedure;
- benign or malignant biliary stricture.
Key Trial Info
Start Date :
May 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03795584
Start Date
May 1 2018
End Date
May 1 2021
Last Update
August 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hosptial
Beijing, Beijing Municipality, China, 100000